131 related articles for article (PubMed ID: 6092904)
1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
Balzarini J; De Clercq E; Ayusawa D; Seno T
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
[TBL] [Abstract][Full Text] [Related]
4. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
Fischer PH; Murphy DG; Kawahara R
Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antiherpetic activity of 2'-fluoro-5-iodo-ara-C in rabbit eyes and cell cultures.
Trousdale MD; Nesburn AB; Watanabe KA; Fox JJ
Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):826-32. PubMed ID: 6273355
[TBL] [Abstract][Full Text] [Related]
6. Repair of DNA following incorporation of 1-beta-D-arabinofuranosylcytosine into herpes simplex virus type 1.
Bubley GJ; Crumpacker CS; Schnipper LE
Cancer Res; 1984 May; 44(5):1813-8. PubMed ID: 6324990
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
Kreis W; Damin L; Colacino J; Lopez C
Biochem Pharmacol; 1982 Mar; 31(5):767-73. PubMed ID: 7082345
[TBL] [Abstract][Full Text] [Related]
8. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
De Clercq E; Balzarini J; Descamps J; Huang GF; Torrence PF; Bergstrom DE; Jones AS; Serafinowski P; Verhelst G; Walker RT
Mol Pharmacol; 1982 Jan; 21(1):217-23. PubMed ID: 7132959
[TBL] [Abstract][Full Text] [Related]
9. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
Kufe D; Herrick D; Crumpacker C; Schnipper L
Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
[TBL] [Abstract][Full Text] [Related]
11. Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.
Young CW; Schneider R; Leyland-Jones B; Armstrong D; Tan CT; Lopez C; Watanabe KA; Fox JJ; Philips FS
Cancer Res; 1983 Oct; 43(10):5006-9. PubMed ID: 6309380
[TBL] [Abstract][Full Text] [Related]
12. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
Balzarini J; Bernaerts R; Verbruggen A; De Clercq E
Mol Pharmacol; 1990 Mar; 37(3):402-7. PubMed ID: 2156154
[TBL] [Abstract][Full Text] [Related]
13. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Reefschläger J; Bärwolff D; Herrmann G; Langen P
Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts.
Colacino JM; Lopez C
Antimicrob Agents Chemother; 1985 Aug; 28(2):252-8. PubMed ID: 3010842
[TBL] [Abstract][Full Text] [Related]
15. Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells.
Kong XB; Scheck AC; Price RW; Vidal PM; Fanucchi MP; Watanabe KA; Fox JJ; Chou TC
Antiviral Res; 1988 Dec; 10(4-5):153-66. PubMed ID: 2852483
[TBL] [Abstract][Full Text] [Related]
16. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
De Clercq E; Bères J; Bentrude WG
Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
[TBL] [Abstract][Full Text] [Related]
17. Methylation of HSV-1 DNA as a mechanism of viral inhibition: studies of an analogue of methyldeoxycytidine: trifluoromethyldeoxycytidine (F3mdCyd).
Barletta J; Greer SB
Antiviral Res; 1992 May; 18(1):1-25. PubMed ID: 1384426
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Ross DD; Chen SR; Cuddy DP
Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of metabolites of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues.
Grant AJ; Feinberg A; Chou TC; Watanabe KA; Fox JJ; Philips FS
Biochem Pharmacol; 1982 Mar; 31(6):1103-8. PubMed ID: 7082364
[TBL] [Abstract][Full Text] [Related]
20. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]